CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 9 of 15

Osteoporosis International

Briefs 321–360 of 576 CurrentRheuma has covered from this journal, newest publication first

Latest from Osteoporosis International

All coverage, newest first

  1. Osteoporos Int

    Early-life famine exposure and risk of osteoporosis and low bone mineral density: a systematic review and meta-analysis

    Meta-analysisOsteoporosis

  2. Osteoporos Int

    Intraoperative physician assessment during total hip arthroplasty correlates with DXA parameters

    Cohort studyOsteoporosis

  3. Osteoporos Int

    Trends in hip fracture rates in US male veterans

    Cohort studyOsteoporosis

  4. Osteoporos Int

    Clinical features of fallers and non-fallers: finding best-performing combinations of physical performance measurements to discriminate physical impairments between fallers and non-fallers among older adults with and without osteoporosis

    Cross-sectional studyOsteoporosis

  5. Osteoporos Int

    Causal associations of osteoporosis with stroke: a bidirectional Mendelian randomization study

    Research articleOsteoporosis

  6. Osteoporos Int

    Diagnostic accuracy of artificial intelligence models in detecting osteoporosis using dental images: a systematic review and meta-analysis

    Meta-analysisOsteoporosis

  7. Osteoporos Int

    An electronic health record (EHR)-based risk calculator can predict fractures comparably to FRAX: a proof-of-concept study

    Diagnostic or prognostic studyOsteoporosis

  8. Osteoporos Int

    Fracture risk assessment in the presence of competing risk of death

    Diagnostic or prognostic studyOsteoporosis

  9. Osteoporos Int

    Association of proton-density fat fraction with osteoporosis: a systematic review and meta-analysis

    Meta-analysisOsteoporosis

  10. Osteoporos Int

    Assessing the causal relationship between plasma proteins and osteoporosis: novel insights into pathological mechanisms and therapeutic implications

    Research articleOsteoporosis

  11. Osteoporos Int

    The Healing and therapeutic effects of perioperative bisphosphonate use in patients with fragility fractures: meta-analysis of 19 clinical trials

    Meta-analysisOsteoporosis

  12. Osteoporos Int

    One versus 2 years of alendronate following denosumab: the CARD extension

    Randomized controlled trialOsteoporosis

  13. Osteoporos Int

    Real-world efficacy of a teriparatide biosimilar (RGB-10) compared with reference teriparatide on bone mineral density, trabecular bone score, and bone parameters assessed using quantitative ultrasound, 3D-SHAPER® and high-resolution peripheral computer tomography in postmenopausal women with osteoporosis and very high fracture risk

    Cohort studyOsteoporosis

  14. Osteoporos Int

    Sex differences and predictors of anti-osteoporosis medication use in the 12 months after hip fracture surgery in adults 65 or older

    Cohort studyOsteoporosis

  15. Osteoporos Int

    The diagnostic value of MRI-based vertebral bone quality score for osteoporosis or osteopenia in patients undergoing lumbar surgery: a meta-analysis

    Meta-analysisOsteoporosis

  16. Osteoporos Int

    Group-based trajectories of potentially preventable hospitalisations among older adults after a hip fracture

    Cohort studyOsteoporosis

  17. Osteoporos Int

    Risk factors associated with 1-year mortality after osteoporotic hip fracture in Hawaiʻi: higher mortality risk among Native Hawaiians and other Pacific Islanders

    Cohort studyOsteoporosis

  18. Osteoporos Int

    Type 2 diabetes incidence in patients initiating denosumab or alendronate treatment: a primary care cohort study

    Cohort studyOsteoporosis

  19. Osteoporos Int

    Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis

    Randomized controlled trialOsteoporosis

  20. Osteoporos Int

    Non-osteoporotic fractures are associated with increased risk of subsequent major osteoporotic fractures

    Cohort studyOsteoporosis

  21. Osteoporos Int

    Artificial intelligence-enhanced opportunistic screening of osteoporosis in CT scan: a scoping Review

    Research articleOsteoporosis

  22. Osteoporos Int

    Increased risk of hip and major osteoporotic fractures in 8463 patients who have undergone stem cell transplantation, a Swedish population-based study

    Cohort studyOsteoporosis

  23. Osteoporos Int

    Birth weight and birth length affect future fracture risk differently in men and women

    Cohort studyOsteoporosis

  24. Osteoporos Int

    Associations between new obesity indices and abnormal bone density in type 2 diabetes mellitus patients

    Cross-sectional studyOsteoporosis

  25. Osteoporos Int

    Chemokine CXCL9, a marker of inflammaging, is associated with changes of muscle strength and mortality in older men

    Cohort studyOsteoporosis

  26. Osteoporos Int

    Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk

    Guideline or statementOsteoporosis

  27. Osteoporos Int

    B vitamins and bone health: a meta-analysis with trial sequential analysis of randomized controlled trials

    Meta-analysisOsteoporosis

  28. Osteoporos Int

    Low-dose glucocorticoid increase the risk of fracture in postmenopausal women with low bone mass: a retrospective cohort study

    Cohort studyOsteoporosis

  29. Osteoporos Int

    Opportunistic use of lumbar computed tomography and magnetic resonance imaging for osteoporosis screening

    Diagnostic or prognostic studyOsteoporosis

  30. Osteoporos Int

    The hip fracture incidence in the high-risk area Oslo continues to decline

    Cohort studyOsteoporosis

  31. Osteoporos Int

    The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland

    Cohort studyOsteoporosis

  32. Osteoporos Int

    Educational gradient in hip fracture incidence in Norway. The Norwegian Epidemiologic Osteoporosis Studies (NOREPOS)

    Cohort studyOsteoporosis

  33. Osteoporos Int

    The association of microvascular disease and endothelial dysfunction with vertebral trabecular bone mineral density : The MESA study

    Cross-sectional studyOsteoporosis

  34. Osteoporos Int

    Undiagnosed vertebral fragility fractures in patients with distal radius fragility fractures: an opportunity for prevention of morbimortality in osteoporotic patients in developing countries

    Cross-sectional studyOsteoporosis

  35. Osteoporos Int

    Prior fragility fractures are associated with a higher risk of 8-year complications following total shoulder arthroplasty

    Cohort studyOsteoporosis

  36. Osteoporos Int

    A comparison of foot fractures relative to other fragility fractures: a review and analysis of the American Orthopaedic Association’s Own the Bone Database

    Cohort studyOsteoporosis

  37. Osteoporos Int

    Sex differences in hemoglobin levels and five-year refracture risk in patients with osteoporotic fractures: a retrospective cohort analysis

    Cohort studyOsteoporosis

  38. Osteoporos Int

    Hip fractures in patients with primary aldosteronism – a Swedish nationwide study

    Cohort studyOsteoporosis

  39. Osteoporos Int

    Introduction of an order set after hip fracture improves osteoporosis medication initiation and persistence: a population-based before-after analysis

    Cohort studyOsteoporosis

  40. Osteoporos Int

    Epidemiology of hip fractures in Thailand

    Cohort studyOsteoporosis

All 576 Briefs in ExploreShowing Briefs 321–360 of 576, newest first